DK544883A - Stabile plurilamellare vesikler - Google Patents

Stabile plurilamellare vesikler Download PDF

Info

Publication number
DK544883A
DK544883A DK544883A DK544883A DK544883A DK 544883 A DK544883 A DK 544883A DK 544883 A DK544883 A DK 544883A DK 544883 A DK544883 A DK 544883A DK 544883 A DK544883 A DK 544883A
Authority
DK
Denmark
Prior art keywords
vesicles
aqueous phase
stable
dispersion
organic solvent
Prior art date
Application number
DK544883A
Other languages
English (en)
Other versions
DK544883D0 (da
DK163105C (da
DK163105B (da
Inventor
Robert Parker Lenk
Michael Wayne Fountain
Andrew Stuart Janoff
Marc Jeffrey Ostro
Micrea Constantine Popescu
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/476,496 external-priority patent/US4522803A/en
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of DK544883D0 publication Critical patent/DK544883D0/da
Publication of DK544883A publication Critical patent/DK544883A/da
Publication of DK163105B publication Critical patent/DK163105B/da
Application granted granted Critical
Publication of DK163105C publication Critical patent/DK163105C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK544883A 1982-03-29 1983-11-28 Fremgangsmaade til fremstilling af stabile plurilamellare vesikler DK163105C (da)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US36299482A 1982-03-29 1982-03-29
US36299582A 1982-03-29 1982-03-29
US36299482 1982-03-29
US36299582 1982-03-29
US41146682A 1982-08-25 1982-08-25
US41146682 1982-08-25
US44724782A 1982-12-06 1982-12-06
US44724782 1982-12-06
US46390083A 1983-02-04 1983-02-04
US46390083 1983-02-04
US47649683 1983-03-24
PCT/US1983/000419 WO1983003383A1 (en) 1982-03-29 1983-03-24 Stable plurilamellar vesicles
US06/476,496 US4522803A (en) 1983-02-04 1983-03-24 Stable plurilamellar vesicles, their preparation and use
US8300419 1983-03-24

Publications (4)

Publication Number Publication Date
DK544883D0 DK544883D0 (da) 1983-11-28
DK544883A true DK544883A (da) 1983-11-28
DK163105B DK163105B (da) 1992-01-20
DK163105C DK163105C (da) 1992-06-15

Family

ID=27559847

Family Applications (1)

Application Number Title Priority Date Filing Date
DK544883A DK163105C (da) 1982-03-29 1983-11-28 Fremgangsmaade til fremstilling af stabile plurilamellare vesikler

Country Status (14)

Country Link
EP (1) EP0092453B1 (da)
AU (1) AU564876B2 (da)
DD (1) DD210217A5 (da)
DE (1) DE3373273D1 (da)
DK (1) DK163105C (da)
FI (1) FI83161C (da)
GR (1) GR78163B (da)
HK (1) HK96190A (da)
IE (1) IE54706B1 (da)
IL (1) IL68250A (da)
NZ (1) NZ203746A (da)
PT (1) PT76476B (da)
SG (1) SG13489G (da)
WO (1) WO1983003383A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030453A (en) * 1983-03-24 1991-07-09 The Liposome Company, Inc. Stable plurilamellar vesicles
DE3336583A1 (de) * 1983-09-26 1985-04-25 Udo Dr. 8400 Regensburg Ehrenfeld Erzeugnis zur diagnose und therapie von malignen tumoren
DE3486459D1 (de) * 1983-09-26 1997-12-11 Udo Dr Med Ehrenfeld Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
CH668554A5 (de) * 1984-04-09 1989-01-13 Sandoz Ag Liposomen welche polypeptide mit interleukin-2-aktivitaet enthalten sowie verfahren zu ihrer herstellung.
AU591466B2 (en) * 1984-10-22 1989-12-07 Vestar, Inc. Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body
EP0179660A3 (en) * 1984-10-26 1987-08-12 The Liposome Company, Inc. Multilayered vesicles prepared by reverse-phase evaporation
BE902199A (fr) * 1984-10-29 1985-07-31 Vira Tek Inc Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide.
US5409704A (en) * 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
DE3689769T2 (de) * 1985-07-05 1994-07-21 Liposome Co Inc Multilamellare liposome mit verbesserter einschliessungswirkung.
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
US4983397A (en) * 1985-08-19 1991-01-08 Board Of Regents, University Of Texas System Pharmaceutical compositions consisting of acylated phospholipids
US5068198A (en) * 1986-03-26 1991-11-26 Syntex (U.S.A.) Inc. Liquid single reagent for assays involving confining gels
NZ219745A (en) * 1986-03-26 1990-06-26 Syntex Inc Single liquid reagent for analyte binding type assays
JPH0751496B2 (ja) * 1986-04-02 1995-06-05 武田薬品工業株式会社 リポソ−ムの製造法
ES2036593T3 (es) * 1986-06-12 1993-06-01 The Liposome Company, Inc. Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
EP0256989A1 (en) * 1986-08-18 1988-02-24 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
FR2648462B1 (fr) * 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
HUP0302352A3 (en) 2000-11-09 2007-03-28 Neopharm Sn-38 lipid complexes and methods of use
WO2003030864A1 (en) 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
DE102008005673A1 (de) * 2008-01-23 2009-08-20 Universität Augsburg Bläschen, sowie Verfahren zur Herstellung und Manipulation von Bläschen
US10307491B2 (en) 2015-01-30 2019-06-04 The Regents Of The University Of Michigan Liposomal particles comprising biological molecules and uses thereof
AU2016238290B9 (en) 2015-03-25 2019-06-13 The Regents Of The University Of Michigan Compositions and methods for delivery of biomacromolecule agents
WO2017127503A2 (en) * 2016-01-19 2017-07-27 The Regents Of The University Of Michigan Vesicle-encapsulated socs
EP3471778A4 (en) 2016-06-20 2020-02-19 The Regents of The University of Michigan COMPOSITIONS AND METHOD FOR DELIVERING BIOMACROMOLECOLIC ACTIVE SUBSTANCES
WO2020123362A1 (en) 2018-12-10 2020-06-18 EternaTear, Inc. Ophthalmic formulations providing durable ocular lubrication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115544A (en) * 1976-08-18 1978-09-19 Alza Corporation Ocular system made of bioerodible esters having linear ether
CH624011A5 (da) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles

Also Published As

Publication number Publication date
EP0092453A2 (en) 1983-10-26
DK544883D0 (da) 1983-11-28
DK163105C (da) 1992-06-15
IE54706B1 (en) 1990-01-17
IL68250A (en) 1990-02-09
IL68250A0 (en) 1983-06-15
AU564876B2 (en) 1987-08-27
NZ203746A (en) 1987-03-06
EP0092453A3 (en) 1983-12-07
FI83161B (fi) 1991-02-28
SG13489G (en) 1989-07-07
FI834364A7 (fi) 1983-11-29
DD210217A5 (de) 1984-06-06
HK96190A (en) 1990-11-30
FI83161C (fi) 1991-06-10
GR78163B (da) 1984-09-26
WO1983003383A1 (en) 1983-10-13
PT76476A (en) 1983-04-01
FI834364A0 (fi) 1983-11-29
EP0092453B1 (en) 1987-09-02
PT76476B (en) 1985-12-10
DE3373273D1 (de) 1987-10-08
IE830690L (en) 1983-09-29
DK163105B (da) 1992-01-20
AU1519683A (en) 1983-10-24

Similar Documents

Publication Publication Date Title
PL342473A1 (en) Method of obtaining a mixture of lipides and suspension of phopholipides containing such mixture
EP0322786A3 (en) Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
ES2107668T3 (es) Liposomas, procedimiento para su preparacion y su uso en la elaboracion de un medicamento.
IE780464L (en) Liposome compositions
ES8603801A1 (es) Un metodo para preparar derivados de alcanoles aromaticos policiclicos
CA2227761A1 (en) Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers
GB2249956B (en) Transdermal device with dual solvent for active ingredient
IE811298L (en) Magnetically-localizable biodegradable lipid microspheres
IE830690L (en) Stable plurilamellar vesicles
GB2136762B (en) Process for preparing lipid vesicles by vaporisation of solvents
ES542483A0 (es) Procedimiento de preparacion de una forma galenica para ad- ministracion por via oral
ES508174A0 (es) "un procedimiento para obtener vesiculas".
AU1920783A (en) Process for the preparation of sculphonated aryl phosphines
ES8606322A1 (es) Procedimiento para preparar derivados de benzodifuranona
NO913816L (no) Fremstilling av liposom- og lipidkompleksblandinger.
EP0259495A4 (en) Process for producing egg yolk lecithin containing a reduced amount of pe and/or containing substantially no impurities.
KR890700021A (ko) 인지질 조성물
CO4480019A1 (es) Liposomas de cetoprofeno
KR880008802A (ko) 수불용성 유효 성분의 인지질 전달 매체
KR910015308A (ko) 빌로발리드 유도체, 그 용도 및 이를 함유한 제제
ES2062701T3 (es) Procedimiento para refino de mezclas procedentes de tratamientos de medios grasos con ayuda de ciclodextrina y comprendiendo complejos de ciclodextrina esencialmente con substancias lipofilicas distintas de los acidos grasos.
ES2093701T3 (es) Procedimiento para la preparacion de suspensiones acuosas de liposomas que contienen sustancias activas.
DE3878922D1 (de) Mehrstufen-einkapselungs/ladeverfahren zur herstellung von lipophile heilmittel enthaltenden liposomen.
ZA884513B (en) Drug emulsion
ES533932A0 (es) Procedimiento para preparar esteres de acidos benzosulfonicos substituidos

Legal Events

Date Code Title Description
PUP Patent expired